You are here

Micro Vide, LLC

Company Information
Address
1266 Candlewood Cir
Blythewood, SC 29016-8272
United States



Information

DUNS: 829822415

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Proteolytic Imaging of Remodeling Myocardium

    Amount: $1,814,061.00

    DESCRIPTIONprovided by applicantProteolytic Imaging of Remodeling Myocardium Abstract Heart attacksi emyocardial infarction or MIoccur in more thanmillion patients annuallyAdvances in interventional a ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  2. Reversal of Myocardial Infarction by Localized Stimulation

    Amount: $984,046.00

    DESCRIPTION provided by applicant Heart attacks i e myocardial infarction or MI occur in more than million patients annually Advances in pharmacological therapy have dramatically improved s ...

    STTRPhase II2014Department of Health and Human Services National Institutes of Health
  3. Reversal of Myocardial Infarction by Localized Stimulation

    Amount: $207,628.00

    DESCRIPTION (provided by applicant): Heart attacks (i.e. myocardial infarction or MI) occur in more than 1.2 million patients annually. Advances in pharmacological therapy have dramatically improved s ...

    STTRPhase I2013Department of Health and Human Services National Institutes of Health
  4. Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery

    Amount: $694,875.00

    DESCRIPTION (provided by applicant): A major cause of morbidity and mortality in cardiovascular surgery is excessive bleeding post- operatively, which is commonly managed by pharmacologically modifyin ...

    STTRPhase II2011Department of Health and Human Services National Institutes of Health
  5. Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery

    Amount: $117,453.00

    DESCRIPTION (provided by applicant): A major cause of morbidity and mortality in cardiovascular surgery is excessive bleeding post- operatively, which is commonly managed by pharmacologically ...

    STTRPhase I2010Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government